CANF Stock Price Prediction 2026
Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares
$4.01
$-0.09
(-2.2%)
AI-powered price predictions based on fundamental analysis and growth projections
Last Updated: January 30, 2026
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
- Volume showing accumulation (CMF: 0.6303)
MACD: Bearish
|
Volume: Accumulation
Volume Trend: Accumulation
Institutional Buying Detected - Smart money is accumulating shares
Chaikin Money Flow (CMF):
0.630
Money Flow Index (MFI):
56.7
Positive CMF indicates money flowing into the stock. This bullish signal suggests institutional interest.
Price Targets by Timeframe
AI-based growth projections (not Wall Street analyst targets)
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $3.97 | -1.0% |
| 90 Days | $3.88 | -3.2% |
| 6 Months | $3.75 | -6.4% |
| 1 Year | $3.50 | -12.7% |
More CANF Analysis
CANF Price Prediction Trendline
Scenario Analysis (1-Year Outlook)
Bull Case
30% Probability
$4.38
(+9.1%)
Best case scenario if strong fundamentals and market conditions align
Base Case
50% Probability
$3.50
(+-12.7%)
Expected scenario based on current growth trajectory
Bear Case
20% Probability
$2.45
(-38.9%)
Downside scenario if market headwinds or disappointing results
Technical Indicators
RSI (14)
64.5
Neutral
MACD Signal
Bearish
Trend
Downtrend
Money Flow (CMF)
0.63
Key Fundamentals
Forward P/E
2.97
P/S Ratio (TTM)
27.21x
High Premium
Revenue Growth (QoQ)
-0.4%
Market Cap
$15M
Analyst Target
$3.50
52-Week High
$4.19
52-Week Low
$4.00
Investment Disclaimer:
These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.